4-(8-Propyl-2,4-dithioxo-1,3-diazaspiro[4.5]decan-3-yl)spiro[1,5-dihydro-1,5-benzodiazepine-2,3′-indoline]-2′-one)

A number of 1D and 2D NMR techniques, such as <sup>1</sup>H, <sup>13</sup>C, DEPT 135, <sup>1</sup>H-<sup>1</sup>H COSY, HSQC, and HMBC, were utilized for the structure verification of 4-(8-propyl-2,4-dithioxo-1,3-diazaspiro[4.5]decan-3-yl)spiro[1,5-di...

وصف كامل

التفاصيل البيبلوغرافية
الحاوية / القاعدة:Molbank
المؤلفون الرئيسيون: Dimitar Stoitsov, Marin Marinov, Plamen Penchev, Neyko Stoyanov
التنسيق: مقال
اللغة:الإنجليزية
منشور في: MDPI AG 2025-05-01
الموضوعات:
الوصول للمادة أونلاين:https://www.mdpi.com/1422-8599/2025/2/M2011
الوصف
الملخص:A number of 1D and 2D NMR techniques, such as <sup>1</sup>H, <sup>13</sup>C, DEPT 135, <sup>1</sup>H-<sup>1</sup>H COSY, HSQC, and HMBC, were utilized for the structure verification of 4-(8-propyl-2,4-dithioxo-1,3-diazaspiro[4.5]decan-3-yl)spiro[1,5-dihydro-1,5-benzodiazepine-2,3′-indoline]-2′-one). The NMR spectra provided evidence for the tautomeric conversion of the compound. The completely assigned NMR data was supported additionally by ATR.
تدمد:1422-8599